Inventor
PHILLIPS ANDREW J
US24 patents
⚠️ This page may combine multiple inventors who share the name “PHILLIPS ANDREW J”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
C4 THERAPEUTICS INC
16 patentsUS11185592B2Nov 30, 2021
Spirocyclic degronimers for target protein degradation
C4 THERAPEUTICS INC20 citations93
US10905768B1Feb 2, 2021
Heterocyclic degronimers for target protein degradation
C4 THERAPEUTICS INC31 citations93
US10660968B2May 26, 2020
Spirocyclic degronimers for target protein degradation
C4 THERAPEUTICS INC32 citations93
US10646575B2May 12, 2020
Heterocyclic degronimers for target protein degradation
C4 THERAPEUTICS INC32 citations93
US10849982B2Dec 1, 2020
C3-carbon linked glutarimide degronimers for target protein degradation
C4 THERAPEUTICS INC43 citations92
US11524949B2Dec 13, 2022
Degraders and Degrons for targeted protein degradation
C4 THERAPEUTICS INC7 citations85
US11459335B2Oct 4, 2022
N/O-linked Degrons and Degronimers for protein degradation
C4 THERAPEUTICS INC8 citations85
US12048747B2Jul 30, 2024
Substituted piperidine Degronimers for Target Protein degradation
C4 THERAPEUTICS INC4 citations74
US11992531B2May 28, 2024
C3-carbon linked glutarimide degronimers for target protein degradation
C4 THERAPEUTICS INC3 citations73
US12570626B2Mar 10, 2026
Degraders and degrons for targeted protein degradation
C4 THERAPEUTICS INC0 citations62
US12441740B2Oct 14, 2025
N/O-linked degrons and degronimers for protein degradation
C4 THERAPEUTICS INC0 citations62
US12180225B2Dec 31, 2024
N/O-linked degrons and degronimers for protein degradation
C4 THERAPEUTICS INC1 citations62
US12076405B2Sep 3, 2024
Heterocyclic degronimers for target protein degradation
C4 THERAPEUTICS INC1 citations62
US12048748B2Jul 30, 2024
Spirocyclic degronimers for target protein degradation
C4 THERAPEUTICS INC1 citations62
US11753397B2Sep 12, 2023
Cereblon binders for the degradation of ikaros
C4 THERAPEUTICS INC1 citations62
US12454521B2Oct 28, 2025
Targeted protein degradation
C4 THERAPEUTICS INC0 citations48
DANA FARBER CANCER INST INC
4 patentsUS11311609B2Apr 26, 2022
Regulating chimeric antigen receptors
DANA FARBER CANCER INST INC6 citations71
US11046954B2Jun 29, 2021
Targeted protein degradation to attenuate adoptive T-cell therapy associated adverse inflammatory responses
DANA FARBER CANCER INST INC2 citations71
US11293023B2Apr 5, 2022
Tunable endogenous protein degradation
DANA FARBER CANCER INST INC0 citations61
US12023385B2Jul 2, 2024
Tunable endogenous protein degradation with heterobifunctional compounds
DANA FARBER CANCER INST INC0 citations49
ELECTRIC POWER RES INST
2 patentsUS7002079B2Feb 21, 2006
Indicators for early detection of potential failures due to water exposure of polymer-clad fiberglass
ELECTRIC POWER RES INST42 citations89
US6930254B2Aug 16, 2005
Chemically-doped composite insulator for early detection of potential failures due to exposure of the fiberglass rod
ELECTRIC POWER RES INST7 citations72